Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2018) 56 P421 | DOI: 10.1530/endoabs.56.P421

ECE2018 Poster Presentations: Diabetes, Obesity and Metabolism Diabetes complications (72 abstracts)

Soluble dipeptidyl peptidase-4 activity is associated with decreased renal function in patients with type 2 diabetes

Eun-Hee Cho 1 , Ji Yun Jeong 2 , Mi Young Lee 3 , Jung Min Kim 4 & Mi-Seon Shin 5


1School of Medicine, Kangwon National University, Chuncheon, Republic of Korea; 2Soonchunhyang University, Gumi, Republic of Korea; 3Yonsei University Wonju College of Medicine, Wonju, Republic of Korea; 4Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Republic of Korea; 5Hanil General Hospital, Seoul, Republic of Korea.


Objective: Dipeptidyl peptidase (DPP)-4 is highly abundant in the kidney. In various chronic inflammatory diseases, soluble DPP-4 activity is used as a marker for diabetes, coronary artery disease and cancer. This study examined the association between serum soluble DPP-4 levels and renal function or cardiovascular risk in patients with type 2 diabetes mellitus.

Research design and methods: Soluble DPP-4 activities were measured retrospectively in a total of 120 patients with type 2 diabetes in the preserved samples from our previous coronary artery calcium score study.

Results: The mean soluble DPP-4 level was 645±152 ng/ml. Univariate analyses revealed that soluble DPP-4 activities were significantly correlated with total cholesterol (r=0.214; P=0.019), serum creatinine (r=−0.315; P<0.001), and estimated glomerular filtration rate by the modification of diet in renal disease (MDRD) (r=0.303; P=0.001). Associations between soluble DPP-4 with serum creatinine and GFR by the MDRD equation remained significant after adjustment for body mass index, age, and duration of diabetes. However, there was no association between soluble DPP-4 levels and body mass index, waist circumference, or coronary artery calcium score (CACs).

Conclusions: These data suggest that soluble serum DPP-4 activity might be used as a potential biomarker of deteriorated renal function in patients with T2D.

Volume 56

20th European Congress of Endocrinology

Barcelona, Spain
19 May 2018 - 22 May 2018

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.